CannabisNewsBreaks

FridayJan 24, 2020 12:14 pm

CannabisNewsBreaks – Cresco Labs (CSE: CL) (OTCQX: CRLBF) Enters Senior Secured Credit Agreement

Cresco Labs (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced its entry into a non-brokered credit agreement for a senior secured term loan in an initial aggregate principal amount of up to US$100 million, with a mutual option to increase the size of the facility to a maximum of US$200 million. The company expects to complete an initial drawdown of up to US$100 million on or about January 30, 2020, subject to the satisfaction of customary funding conditions, and intends to use the proceeds for the expansion of operations…

Continue Reading

ThursdayJan 23, 2020 9:28 am

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) to Commence Trading on the Toronto Stock Exchange; Provides Cannabis 2.0 Update

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, today announced that its common shares are set to start trading on the Toronto Stock Exchange (“TSX”) under the symbol ‘VIVO’ at market open on January 24, 2020. The company’s common shares will be voluntarily delisted from the TSX Venture Exchange in connection with the TSX listing. “The strength of the Toronto Stock Exchange is world-class, and this event represents a tremendous milestone for VIVO,” VIVO Cannabis CEO Barry Fishman stated in the news release. “We believe the TSX listing will increase VIVO's…

Continue Reading

WednesdayJan 22, 2020 10:00 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Provide Patented DehydraTECH(TM) to Cannadips’ Cannabis Products in California and Across the US

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that it has reached a new definitive agreement to provide its patented DehydraTECH(TM) technology to Cannadips' cannabis products, both in its current California market and across the United States. According to the update, Lexaria's DehydraTECH fast-acting, high-absorption technology is perfectly suited to improve consumer satisfaction and the dipping experience. Terpene-rich multi spectrum oils are base ingredients of Cannadips THC, and DehydraTECH is able to reduce throat irritation normally associated with some terpenes. Inferior products utilize less efficacious cannabis isolate without terpenes that lack the entourage…

Continue Reading

TuesdayJan 21, 2020 1:28 pm

CannabisNewsBreaks – Namaste Technologies Inc.’s (TSX.V: N) (OTCQB: NXTTF) Position to Capitalize on Changing Cannabis Industry Highlighted in technical420 Article

Namaste Technologies (TSX.V: N) (OTCQB: NXTTF), an online platform for cannabis products, accessories, and responsible education, was highlighted in a recent article by Anthony Varrell on technical420 titled ‘Namaste Technologies Is On Track To Be One Of The Biggest Turnaround Stories of 2020’. Among other highlights, the article discusses some recent key achievements by the company as well as its strategy moving forward. “Through CannMart, Namaste is well positioned to capitalize on the cannabis 2.0 opportunity, and we find this to be significant. The company expects to start selling several new cannabis derivative products in March and to submit up…

Continue Reading

FridayJan 17, 2020 2:16 pm

CannabisNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Slated for Success as Key Advancements Anticipated for Cannabis Industry in 2020

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), a hemp-biomass processing entity, recently entered into a share and purchase agreement with Starling Brands Inc. to acquire Starling’s subsidiary Kase Farma Inc., a company authorized to work with hemp cultivation, extraction, refining, formulation and distribution in California (http://cnw.fm/uMc95). A recent article discussing the company reads, “Starling executives anticipate that 2020 may be the biggest year ever for hemp and cannabis policy reform in the United States, given recent changes in the regulatory landscape such as the 2018 Farm Act’s passage by Congress and the president, the SAFE Banking Act’s passage by the House…

Continue Reading

FridayJan 17, 2020 2:05 pm

CannabisNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Focuses on Offering Premier, Dosable Cannabis Products

Plus Products (CSE: PLUS) (OTCQB: PLPRF), a hemp and cannabis food company using nature to bring balance to consumers’ lives, is concentrating on producing edibles using extracts to ensure compliant, dosable and tasty products that provide a reliable cannabis experience. An article discussing the company reads, “In California, PLUS has established its iconic product: PLUS Gummies (cannabis infused). Its Plus Uplift Sour Watermelon was the best-selling cannabis product in California in 2019. . . . Of note to investors is that Plus Products is centered on quality growth in California and beyond. Its emphasis is on thoughtfully building a brand…

Continue Reading

FridayJan 17, 2020 9:27 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Provides Update on Portfolio Companies

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning provided an update regarding recent announcements from its portfolio companies High Beauty, Inc., TerrAscend Corp. (CSE: TER), YSS Corp. (TSX.V: YSS) and James E. Wagner Cultivation Corp. (TSX.V: JWC) (OTCQX: JWCAF). Per the update, High Beauty will remember 2019 as the year it expanded its retail presence across the U.S., Canada, and Europe. YSS Corp. and James E. Wagner Cultivation Corp. are currently assessing opportunities to increase their retail footprint in Canada, while TerrAscend is taking steps to build out its U.S. operations in 2020.…

Continue Reading

ThursdayJan 16, 2020 9:18 am

CannabisNewsBreaks – Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Boosts Consumer Access to Quality Medical Cannabis Products via Supply Agreement

Organigram Holdings (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced that it has entered a supply agreement with Medical Cannabis by Shoppers, the online medical cannabis platform by Shoppers Drug Mart Inc. The agreement, which is comprised of a three-year term subject to renewal for an additional two years, highlights Organigram’s commitment to provide Canadian consumers access to quality medical cannabis products. Per the terms of the agreement, Organigram will provide Shoppers with a broad array of products such as dried flower, oils and other products as they become available…

Continue Reading

TuesdayJan 14, 2020 10:03 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Agreement to Provide DehydraTECH(TM) Technology to Cannadips CBD

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, this morning announced that it has reached a definitive agreement to provide its patented DehydraTECH(TM) technology to Cannadips CBD, the Original Smokeless CBD Dip Brand. According to the update, each tin of Cannadips contains 15 pouches, each with 10mg of hemp-derived CBD, and includes only natural sweeteners with no tobacco or nicotine. Already established as the leader in CBD oral delivery, Lexaria has been working behind the scenes with the Boldt Runners team to elevate the product experience. “In our quest to create the ultimate smokeless, oral…

Continue Reading

MondayJan 13, 2020 2:22 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH Platform Boosts CBD Absorption Levels

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) innovative DehydraTECH(TM) delivery platform is patented for all nonpsychoactive cannabinoids as well as for tetrahydrocannabinol (THC) and psychoactive cannabinoids. An article discussing the company reads, “Medical researchers have struggled to find ways to penetrate the blood brain barrier effectively to transport beneficial drugs for many years. This barrier exists to block toxic or otherwise dangerous substances from entering the brain and is formed by layers of microvascular endothelial cells inside blood vessels. Lexaria’s DehydraTECH(TM) drug delivery platform brings beneficial drugs to the brain faster. . . . In June 2019, Lexaria completed a series…

Continue Reading